Multidisciplinary approach in the treatment of spinal dural arteriovenous fistula - results of endovascular and surgical treatment

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F18%3A10382856" target="_blank" >RIV/00216208:11150/18:10382856 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00179906:_____/18:10382856

Výsledek na webu

<a href="http://dx.doi.org/10.1007/s00701-018-3672-z" target="_blank" >http://dx.doi.org/10.1007/s00701-018-3672-z</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s00701-018-3672-z" target="_blank" >10.1007/s00701-018-3672-z</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Multidisciplinary approach in the treatment of spinal dural arteriovenous fistula - results of endovascular and surgical treatment

Popis výsledku v původním jazyce

Background The results of treatment for spinal dural arteriovenous fistula (SDAVF) have been controversial. The goal of this study was to compare results of endovascular and surgical treatments to contribute to determining an optimal treatment strategy. Methods A retrospective analysis of the set of 24 SDAVF patients (11 in the endovascular and 13 in the surgical group) was performed. The clinical effect (using the modified Rankin scale [mRS]), the radicality, and the number of clinical recurrences as well as the impact of age, the level of impairment, and the duration of symptoms before the treatment were evaluated. Results The average age was 60.1 +- 8.4 years. The median duration of symptoms before establishing a diagnosis was 12 (1-70) months. Clinical improvement was reported in 11 out of 24 (45.8%) patients (36.4% following embolization and 53.8% following surgery, p = 0.444). Radical performance was achieved in 47.4% of endovascular versus 92.9% of surgical procedures (p = 0.009). Clinical recurrence was reported in 35.3% of patients in the endovascular group, whereas no clinical recurrence was reported in the surgical group (p = 0.0133). The graphical residuum after 1 surgery out of 14 (7.1%) was cured early during the control angiography. Clinical improvement was reported 42.1% of patients with mRS LESS-THAN OR EQUAL TO 3 versus 60% of patients with mRS GREATER-THAN OR EQUAL TO 4 and, in 57.1% of patients aged GREATER-THAN OR EQUAL TO 60 versus in 30% of patients &lt; 60 years (p &gt; 0.05 in both cases). The impact of the duration of symptoms on the clinical results was not statistically significant. Conclusions The surgical treatment of SDAVF appeared to be a more efficient method in terms of the clinical effect, radicality, and lower recurrence rate in comparison with the endovascular treatment. No statistically significant dependence of the clinical result on age, deficit burden, or symptom duration was found.

Název v anglickém jazyce

Multidisciplinary approach in the treatment of spinal dural arteriovenous fistula - results of endovascular and surgical treatment

Popis výsledku anglicky

Background The results of treatment for spinal dural arteriovenous fistula (SDAVF) have been controversial. The goal of this study was to compare results of endovascular and surgical treatments to contribute to determining an optimal treatment strategy. Methods A retrospective analysis of the set of 24 SDAVF patients (11 in the endovascular and 13 in the surgical group) was performed. The clinical effect (using the modified Rankin scale [mRS]), the radicality, and the number of clinical recurrences as well as the impact of age, the level of impairment, and the duration of symptoms before the treatment were evaluated. Results The average age was 60.1 +- 8.4 years. The median duration of symptoms before establishing a diagnosis was 12 (1-70) months. Clinical improvement was reported in 11 out of 24 (45.8%) patients (36.4% following embolization and 53.8% following surgery, p = 0.444). Radical performance was achieved in 47.4% of endovascular versus 92.9% of surgical procedures (p = 0.009). Clinical recurrence was reported in 35.3% of patients in the endovascular group, whereas no clinical recurrence was reported in the surgical group (p = 0.0133). The graphical residuum after 1 surgery out of 14 (7.1%) was cured early during the control angiography. Clinical improvement was reported 42.1% of patients with mRS LESS-THAN OR EQUAL TO 3 versus 60% of patients with mRS GREATER-THAN OR EQUAL TO 4 and, in 57.1% of patients aged GREATER-THAN OR EQUAL TO 60 versus in 30% of patients &lt; 60 years (p &gt; 0.05 in both cases). The impact of the duration of symptoms on the clinical results was not statistically significant. Conclusions The surgical treatment of SDAVF appeared to be a more efficient method in terms of the clinical effect, radicality, and lower recurrence rate in comparison with the endovascular treatment. No statistically significant dependence of the clinical result on age, deficit burden, or symptom duration was found.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30103 - Neurosciences (including psychophysiology)

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Acta Neurochirurgica

ISSN

0001-6268

e-ISSN

—

Svazek periodika

160

Číslo periodika v rámci svazku

12

Stát vydavatele periodika

AT - Rakouská republika

Počet stran výsledku

10

Strana od-do

2439-2448

Kód UT WoS článku

000450984500024

EID výsledku v databázi Scopus

2-s2.0-85053502875